OPR - Delayed Quote • USD BCYC Jun 2024 7.500 put (BCYC240621P00007500) Follow 0.5000 0.0000 (0.00%) As of January 16 at 9:30 AM EST. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for BCYC240621P00007500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: BCYC Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference Bicycle Therapeutics to Present at the AACR Annual Meeting 2024 Bicycle Therapeutics to Participate in Upcoming Investor Conferences Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference 15 Small-Cap Stocks with High Potential Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day Bicycle Therapeutics to Host R&D Day on December 14
